my News icon
twitterfacebook
google
News image
Reuters-US Senate Democrats to try to pass bill protecting in vitro fertilization

By Richard Cowan WASHINGTON (Reuters) - Democrats on Wednesday will try rushing legislation through the U.S. Senate guaranteeing Americans' access to in vitro fertilization and other assisted

News image
Reuters-Biotech company bets on GMO mosquitoes to fight dengue in Brazil as cases surge

By Leonardo Benassatto (Reuters) - British biotechnology company Oxitec is betting on a solution to Brazil's surging dengue cases, involving the release of genetically modified mosquitoes in an effort

News image
Reuters-Exclusive-Eli Lilly could launch obesity drug in India next year, CEO says

By Rishika Sadam and Leroy Leo HYDERABAD (Reuters) -U.S. drugmaker Eli Lilly expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next

News image
Reuters-Novavax says still faces strong headwinds, 2024 sales flat to lower

By Michael Erman (Reuters) -COVID-19 vaccine maker Novavax on Wednesday said it still faces significant financial difficulties and expects revenue this year to be flat or lower as it works to pick up

News image
Reuters-In South Korea, world's lowest fertility rate plunges again in 2023

By Jihoon Lee and Cynthia Kim SEOUL (Reuters) -South Korea's fertility rate, already the world's lowest, continued its dramatic decline in 2023, as women concerned about their career advancement and

News image
Reuters-South Korea to send military doctors to hospitals amid doctors' protest

By Jack Kim SEOUL (Reuters) - South Korea will send its military and community doctors to hospitals within the next few days as part of emergency measures to support the healthcare system after a mass

News image
Reuters-Reckitt's quarterly sales disappoint after investigation into Middle East business

By Richa Naidu LONDON (Reuters) -Consumer goods group Reckitt on Wednesday missed fourth-quarter like-for-like net sales expectations as an investigation showed some employees had under-reported

News image
Reuters-Viatris forecasts strong 2024 sales on higher demand for branded drugs

(Reuters) - Drugmaker Viatris forecast annual revenue above Wall Street estimates on Wednesday, banking on strong demand for its branded drugs such as Yupelri for lung disease and Breyna for asthma.

News image
Reuters-Vivani shares skyrocket as implant reduces weight in mice

(Reuters) - Vivani Medical shares surged more than five-fold in early trading on Wednesday after the drug developer said its experimental under-the-skin drug implant helped reduce weight in obese mice

news ad
my News icon
twitterfacebook
google
© 2024 EarthLink, LLC All rights reserved.
Members and visitors to the EarthLink Web site agree to abide by our Policies and Agreements, including the Acceptable Use Policy.
EarthLink Privacy Policy